Skip to Main Content

Author Details

Gary S Stein
University of Vermont
1968
826
113
PMIDPaper TitleJournal TitlePublished Year
36191822The lysine methyltransferases SET and MYND domain containing 2 (Smyd2) and Enhancer of Zeste 2 (Ezh2) co-regulate osteoblast proliferation and mineralization.Gene2023
36191822The lysine methyltransferases SET and MYND domain containing 2 (Smyd2) and Enhancer of Zeste 2 (Ezh2) co-regulate osteoblast proliferation and mineralization.Gene2023
37593409Protein arginine methyltransferases PRMT1, PRMT4/CARM1 and PRMT5 have distinct functions in control of osteoblast differentiation.Bone Rep2023
37985890LINC01638 sustains human mesenchymal stem cell self-renewal and competency for osteogenic cell fate.Sci Rep2023
37693373LINC01638 Sustains Human Mesenchymal Stem Cell Self-Renewal and Competency for Osteogenic Cell Fate.Res Sq2023
37693373LINC01638 Sustains Human Mesenchymal Stem Cell Self-Renewal and Competency for Osteogenic Cell Fate.Res Sq2023
37017672Spatiotemporal Epigenetic Control of the Histone Gene Chromatin Landscape during the Cell Cycle.Crit Rev Eukaryot Gene Expr2023
36940196Identification of molecularly unique tumor-associated mesenchymal stromal cells in breast cancer patients.PLoS One2023
37048137Cbfβ Is a Novel Modulator against Osteoarthritis by Maintaining Articular Cartilage Homeostasis through TGF-β Signaling.Cells2023
37593409Protein arginine methyltransferases PRMT1, PRMT4/CARM1 and PRMT5 have distinct functions in control of osteoblast differentiation.Bone Rep2023
37693373LINC01638 Sustains Human Mesenchymal Stem Cell Self-Renewal and Competency for Osteogenic Cell Fate.Res Sq2023
37693373LINC01638 Sustains Human Mesenchymal Stem Cell Self-Renewal and Competency for Osteogenic Cell Fate.Res Sq2023
37985890LINC01638 sustains human mesenchymal stem cell self-renewal and competency for osteogenic cell fate.Sci Rep2023
37048137Cbfβ Is a Novel Modulator against Osteoarthritis by Maintaining Articular Cartilage Homeostasis through TGF-β Signaling.Cells2023
37017672Spatiotemporal Epigenetic Control of the Histone Gene Chromatin Landscape during the Cell Cycle.Crit Rev Eukaryot Gene Expr2023
36940196Identification of molecularly unique tumor-associated mesenchymal stromal cells in breast cancer patients.PLoS One2023
35027560The breast pre-cancer atlas illustrates the molecular and micro-environmental diversity of ductal carcinoma in situ.NPJ Breast Cancer2022
35836997The Shared Core Resource as a Partner in Innovative Scientific Research: Illustration from an Academic Microscopy Imaging Center.J Biomol Tech2022
36348114Epigenetic-Mediated Regulation of Gene Expression for Biological Control and Cancer: Cell and Tissue Structure, Function, and Phenotype.Results Probl Cell Differ2022
36348114Epigenetic-Mediated Regulation of Gene Expression for Biological Control and Cancer: Cell and Tissue Structure, Function, and Phenotype.Results Probl Cell Differ2022
36348115Epigenetic-Mediated Regulation of Gene Expression for Biological Control and Cancer: Fidelity of Mechanisms Governing the Cell Cycle.Results Probl Cell Differ2022
36348115Epigenetic-Mediated Regulation of Gene Expression for Biological Control and Cancer: Fidelity of Mechanisms Governing the Cell Cycle.Results Probl Cell Differ2022
35862394Epigenetic and transcriptome responsiveness to ER modulation by tissue selective estrogen complexes in breast epithelial and breast cancer cells.PLoS One2022
35546168LncMIR181A1HG is a novel chromatin-bound epigenetic suppressor of early stage osteogenic lineage commitment.Sci Rep2022
35546168LncMIR181A1HG is a novel chromatin-bound epigenetic suppressor of early stage osteogenic lineage commitment.Sci Rep2022
35922466MicroRNA-101a enhances trabecular bone accrual in male mice.Sci Rep2022
35027560The breast pre-cancer atlas illustrates the molecular and micro-environmental diversity of ductal carcinoma in situ.NPJ Breast Cancer2022
35012895Titanium with nanotopography attenuates the osteoclast-induced disruption of osteoblast differentiation by regulating histone methylation.Biomater Adv2022
35546168LncMIR181A1HG is a novel chromatin-bound epigenetic suppressor of early stage osteogenic lineage commitment.Sci Rep2022
35546168LncMIR181A1HG is a novel chromatin-bound epigenetic suppressor of early stage osteogenic lineage commitment.Sci Rep2022
35836997The Shared Core Resource as a Partner in Innovative Scientific Research: Illustration from an Academic Microscopy Imaging Center.J Biomol Tech2022
35862394Epigenetic and transcriptome responsiveness to ER modulation by tissue selective estrogen complexes in breast epithelial and breast cancer cells.PLoS One2022
35922466MicroRNA-101a enhances trabecular bone accrual in male mice.Sci Rep2022
36348114Epigenetic-Mediated Regulation of Gene Expression for Biological Control and Cancer: Cell and Tissue Structure, Function, and Phenotype.Results Probl Cell Differ2022
36348114Epigenetic-Mediated Regulation of Gene Expression for Biological Control and Cancer: Cell and Tissue Structure, Function, and Phenotype.Results Probl Cell Differ2022
36348115Epigenetic-Mediated Regulation of Gene Expression for Biological Control and Cancer: Fidelity of Mechanisms Governing the Cell Cycle.Results Probl Cell Differ2022
36348115Epigenetic-Mediated Regulation of Gene Expression for Biological Control and Cancer: Fidelity of Mechanisms Governing the Cell Cycle.Results Probl Cell Differ2022
35012895Titanium with nanotopography attenuates the osteoclast-induced disruption of osteoblast differentiation by regulating histone methylation.Biomater Adv2022
34620709Hinfp is a guardian of the somatic genome by repressing transposable elements.Proc Natl Acad Sci U S A2021
33748969Hypoxia-inducible factor 2α is a novel inhibitor of chondrocyte maturation.J Cell Physiol2021
33639056A Peer-Based Strategy to Overcome HPV Vaccination Inequities in Rural Communities: A Physical Distancing-Compliant Approach.Crit Rev Eukaryot Gene Expr2021
33686254Mesenchymal stem cells overexpressing BMP-9 by CRISPR-Cas9 present high in vitro osteogenic potential and enhance in vivo bone formation.Gene Ther2021
33686254Mesenchymal stem cells overexpressing BMP-9 by CRISPR-Cas9 present high in vitro osteogenic potential and enhance in vivo bone formation.Gene Ther2021
34620709Hinfp is a guardian of the somatic genome by repressing transposable elements.Proc Natl Acad Sci U S A2021
33686254Mesenchymal stem cells overexpressing BMP-9 by CRISPR-Cas9 present high in vitro osteogenic potential and enhance in vivo bone formation.Gene Ther2021
33686254Mesenchymal stem cells overexpressing BMP-9 by CRISPR-Cas9 present high in vitro osteogenic potential and enhance in vivo bone formation.Gene Ther2021
33639056A Peer-Based Strategy to Overcome HPV Vaccination Inequities in Rural Communities: A Physical Distancing-Compliant Approach.Crit Rev Eukaryot Gene Expr2021
33748969Hypoxia-inducible factor 2α is a novel inhibitor of chondrocyte maturation.J Cell Physiol2021
31595577Microarray and RNA in situ hybridization assay for recurrence risk markers of breast carcinoma and ductal carcinoma in situ: Evidence supporting the use of diverse pathways panels.J Cell Biochem2020
31595577Microarray and RNA in situ hybridization assay for recurrence risk markers of breast carcinoma and ductal carcinoma in situ: Evidence supporting the use of diverse pathways panels.J Cell Biochem2020
  • 1 - 50 of 1,652

Recommended Authors

Institute of Pathology, University Medical Center
Career Start Year 2002
Number of shared co-authors 0
Genome Opinion Inc.
Career Start Year 2000
Number of shared co-authors 0
David Geffen School of Medicine, University of California los angeles
Career Start Year 1998
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1997
Number of shared co-authors 0
National Center for Advancing Translational Sciences, National Institutes of Health
Career Start Year 1995
Number of shared co-authors 0
Radboud Institute for Molecular Science, Radboud University
Career Start Year 1995
Number of shared co-authors 1
Polytechnic Institute of Leiria
Career Start Year 1994
Number of shared co-authors 2
Showa University School of Medicine
Career Start Year 1994
Number of shared co-authors 0
Clinical Research Division, Fred Hutchinson Cancer Research Center
Career Start Year 1992
Number of shared co-authors 1
National Institute of Child Health & Human Development, National Institutes of Health
Career Start Year 1991
Number of shared co-authors 1
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 1991
Number of shared co-authors 1
National Cancer Institute
Career Start Year 1990
Number of shared co-authors 2
New York University Cancer Institute, New York University School of Medicine
Career Start Year 1989
Number of shared co-authors 1
University of Texas Health
Career Start Year 1989
Number of shared co-authors 0
The Institute of Cancer Research
Career Start Year 1988
Number of shared co-authors 0
Osaka University
Career Start Year 1987
Number of shared co-authors 0
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Career Start Year 1987
Number of shared co-authors 1
Center for Molecular Medicine, University of Georgia
Career Start Year 1986
Number of shared co-authors 2
Western University
Career Start Year 1985
Number of shared co-authors 1
RIKEN Center for Integrative Medical Sciences
Career Start Year 1985
Number of shared co-authors 0
Princess Maxima Center for Pediatric Oncology Research
Career Start Year 1983
Number of shared co-authors 0
Helmholtz Center Munich and Center for Integrated Protein Science Munich (CIPSM)
Career Start Year 1980
Number of shared co-authors 0
HHMI/NYU Langone School of Medicine
Career Start Year 1980
Number of shared co-authors 3
Hollings Cancer Center, Medical University of South Carolina
Career Start Year 1979
Number of shared co-authors 1
Keck School of Medicine of USC
Career Start Year 1978
Number of shared co-authors 1
Merkin Institute for Translational Research, California Institute of Technology
Career Start Year 1976
Number of shared co-authors 2
National Cancer Institute, National Institutes of Health
Career Start Year 1969
Number of shared co-authors 0
Center for Coregulator Research, Baylor College of Medicine
Career Start Year 1964
Number of shared co-authors 2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
Career Start Year 1963
Number of shared co-authors 0
University of California San Diego
Career Start Year 1963
Number of shared co-authors 3

Collaborators

University of Vermont
Co-authored papers 504
Co-authored papers 402
Co-authored papers 26
Co-authored papers 19
Co-authored papers 15
Co-authored papers 12
Tokyo Medical and Dental University (TMDU)
Co-authored papers 8
Harvard Medical School
Co-authored papers 6
Yale Cancer Center and Smilow Cancer Hospital, Yale University School of Medicine
Co-authored papers 6
Co-authored papers 6
Translational Genomics Research Institute (TGen)
Co-authored papers 5
Tufts University School of Dental Medicine
Co-authored papers 4
Tufts University School of Dental Medicine
Co-authored papers 4
Co-authored papers 4
University of Massachusetts Chan Medical School
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Shandong University
Co-authored papers 3
NASA Ames Research Center
Co-authored papers 3
Department of Food Bioengineering, Jeju National University
Co-authored papers 3
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 3
Co-authored papers 2
Albert Einstein College of Medicine
Co-authored papers 2
Co-authored papers 2
University of Sao Paulo
Co-authored papers 2
Co-authored papers 2
Maine Medical Center Research Institute
Co-authored papers 2
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1